Catalogo dei prodotti della ricerca

LATTANZI, Roberta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.545
EU - Europa 1.079
AS - Asia 383
SA - Sud America 41
AF - Africa 27
OC - Oceania 3
Totale 5.078
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.491
IT - Italia 416
IN - India 183
SE - Svezia 170
CN - Cina 127
UA - Ucraina 113
FI - Finlandia 94
AT - Austria 57
DE - Germania 52
CA - Canada 51
SG - Singapore 49
BG - Bulgaria 43
AR - Argentina 39
IE - Irlanda 38
GB - Regno Unito 34
FR - Francia 27
TG - Togo 14
JP - Giappone 10
RO - Romania 9
CI - Costa d'Avorio 6
CZ - Repubblica Ceca 6
BE - Belgio 5
IR - Iran 4
NG - Nigeria 4
MX - Messico 3
NL - Olanda 3
PK - Pakistan 3
SK - Slovacchia (Repubblica Slovacca) 3
TR - Turchia 3
BR - Brasile 2
ES - Italia 2
NZ - Nuova Zelanda 2
RU - Federazione Russa 2
ZA - Sudafrica 2
AU - Australia 1
CH - Svizzera 1
DK - Danimarca 1
GR - Grecia 1
HK - Hong Kong 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
NO - Norvegia 1
PH - Filippine 1
SC - Seychelles 1
Totale 5.078
Salva come PNG Salva come JPEG
Città #
Fairfield 549
Chandler 366
Woodbridge 289
Ashburn 248
Rome 224
Seattle 197
Houston 193
Ann Arbor 178
Cambridge 174
Wilmington 165
Beijing 105
Princeton 102
Plano 83
San Paolo di Civitate 76
Boston 69
Lawrence 68
Vienna 52
New York 44
San Diego 43
Sofia 43
Menlo Park 42
Federal 39
Bremen 37
Millbury 37
Jacksonville 33
Andover 26
Boardman 25
Dublin 23
Ottawa 23
Singapore 22
Norwalk 20
Falls Church 19
Dearborn 14
Lomé 14
Helsinki 13
Paris 13
Toronto 11
Gatineau 9
Des Moines 8
Fremont 7
London 7
Phoenix 7
Abidjan 6
San Mateo 6
Bühl 5
Hefei 5
Indiana 5
Mississauga 5
Brussels 4
Kunming 4
Lappeenranta 4
Latina 4
Devinska Nova Ves 3
Fuzhou 3
Istanbul 3
Kashiwa 3
Lahore 3
Legnano 3
L’Aquila 3
Maddaloni 3
Mexico City 3
Milan 3
Padova 3
Redmond 3
Redwood City 3
San Francisco 3
Teramo 3
Washington 3
Barcelona 2
Bonate Sopra 2
Bridgeville 2
Brindisi 2
Dobbs Ferry 2
Giussano 2
Hounslow 2
Hyderabad 2
Jesi 2
Las Vegas 2
Los Angeles 2
Monmouth Junction 2
Montréal 2
Moscow 2
Muizenberg 2
Nanjing 2
Olevano Romano 2
Oxford 2
Pindamonhangaba 2
Prescot 2
Sacramento 2
Strasbourg 2
Tappahannock 2
Tokyo 2
Umeda 2
Viterbo 2
Aarhus 1
Aberdeen 1
Acton 1
Arnsberg 1
Atlanta 1
Auckland 1
Totale 3.871
Salva come PNG Salva come JPEG
Nome #
Prokineticin system modulation as a new target to counteract the amyloid beta toxicity induced by glutamatergic alterations in an in vitro model of Alzheimer's disease 116
SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF 18,19-DEHYDROBUPRENORPHINE 115
Sensitization of transient receptor potential vanilloid 1 by the prokineticin receptor agonist Bv8 93
N-acetyl-cysteine, a drug that enhances the endogenous activation of group-II metabotropic glutamate receptors, inhibits nociceptive transmission in humans. 92
Chemokines in alzheimer’s disease: new insights into prokineticins, chemokine-like proteins 90
Expression of Bv8 in pichia pastoris to identify structural features for receptor binding 89
Identification and characterization of prokineticin receptor 2 splicing variant and its modulation in an animal model of alzheimer's disease 89
Bv8-Prokineticins and their Receptors: Modulators of Pain 85
Bv8/prokineticin 2 is involved in Aβ-induced neurotoxicity 84
Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice 83
The prokineticin receptor antagonist PC1 rescues memory impairment induced by β amyloid administration through the modulation of prokineticin system 81
Antagonism of the prokineticin system prevents and reverses allodynia and inflammation in a mouse model of diabetes 80
G-CSF related bone pain (BP) and Bv8/PK2 expression: Is there a link in breast cancer (BC) patients (pts) treated with FEC100 adjuvant chemotherapy (CT)? 78
Biological activities of Bv8 analogues 78
PK2β ligand, a splice variant of prokineticin 2, is able to modulate and drive signaling through PKR1 receptor 77
Controlling the activation of the Bv8/prokineticin system reduces neuroinflammation and abolishes thermal and tactile hyperalgesia in neuropathic animals. 77
HIV-1 Tat-induced diarrhea is improved by the PPAR alpha agonist, palmitoylethanolamide, by suppressing the activation of enteric glia 77
Conformationally constrained opioid ligands: The Dmt-Aba and Dmt-Aia versus Dmt-Tic scaffold 73
The chemokine Bv8/prokineticin 2 is up-regulated in inflammatory granulocytes and modulates inflammatory pain 73
Impaired nociception and inflammatory pain sensation in mice lacking the prokineticin receptor PKR1: Focus on interaction between PKR1 and the capsaicin receptor TRPV1 in pain behavior 71
Peripheral administration of prokineticin 2 potently reduces food intake and body weight in mice via the brainstem. 69
Analogues of both Leu- and Met-enkephalin containing a constrained dipeptide isostere prepared from a Baylis-Hillman adduct 67
Prokineticin 2 upregulation in the peripheral nervous system has a major role in triggering and maintaining neuropathic pain in the chronic constriction injury model 67
A palmitoylethanolamide producing lactobacillus paracasei improves clostridium difficile toxin a-induced colitis 67
Bv8, the amphibian homologue of the mammalian prokineticins, modulates ingestive behaviour in rats 66
Nociceptive sensitization by the secretory protein Bv8. 66
PC1, a non-peptide PKR1-preferring antagonist, reduces pain behavior and spinal neuronal sensitization in neuropathic mice 64
Bv8/Prokineticin proteins and their receptors 64
The prokineticin Bv8 sensitizes cutaneous terminals of female mice to heat 64
Antinociceptive activity of a novel buprenorphine analogue 61
The balance of concentration between Prokineticin 2β and Prokineticin 2 modulates the food intake by STAT3 signaling 61
Effects of the intravenous administration of [Lys7]dermorphin on local cerebral glucose utilization in the rat. 60
Pharmacology of amphibian opiate peptides 59
Prokineticins are neuroprotective in models of cerebral ischemia and ischemic tolerance in vitro 59
Pharmacological activity of a Bv8 analogue modified in position 24 59
In vitro and in vivo pharmacological activities of 14-o-phenylpropyloxymorphone, a potent mixed mu/delta/kappa-opioid receptor agonist with reduced constipation in mice 59
Age-related ultrastructural and monoamine oxidase changes in the rat optic nerve 56
Glycodermorphins: opioid peptides with potent and prolonged analgesic activity and enhanced blood-brain barrier penetration 55
Prokineticin Receptor 1 Antagonist PC-10 as a Biomarker for Imaging Inflammatory Pain 54
Novel nociceptin analogues: Synthesis and biological activity 54
The prokineticin receptor agonist Bv8 increases GABA release in the periaqueductal grey and modifies RVM cell activities and thermoceptive reflex in the rat. 54
Novel glycosylated (LyS(7))-dermorphin analogues: synthesis, biological activity and conformational investigations 54
Modulators of Pain: Bv8 and Prokineticins 53
The prokineticin receptor agonist Bv8 decreases IL-10 and IL-4 production in mice splenocytes by activating prokineticin receptor-1 53
A New Convenient Synthetic Method and Preliminary Pharmacological Characterization of Triazinediones as Prokineticin Receptor Antagonists 52
Critical role for prokineticin 2 in CNS autoimmunity 51
Targeting prokineticin system counteracts hypersensitivity, neuroinflammation, and tissue damage in a mouse model of bortezomib-induced peripheral neuropathy 51
Bv8/PK2 and prokineticin receptors: a druggable pronociceptive system 50
Role of Enteric Glia as Bridging Element between Gut Inflammation and Visceral Pain Consolidation during Acute Colitis in Rats 50
New 2 ',6 '-dimethyl-L-tyrosine (Dmt) opioid peptidomimetics based on the Aba-Gly scaffold. Development of unique mu-opioid receptor ligands 49
Triazine Compounds as Antagonists at Bv8-Prokineticin Receptors 49
Identification and characterization of a new splicing variant of prokineticin 2 48
6-N,N-Dimethylamino-2,3-Naphthalimide a New Environment-Sensitive Fluorescent Probe in delta-Selective and mu-Selective Opioid Peptides 47
Opioid peptides: Synthesis and biological activity of new endomorphin analogues 47
Involvement of the chemokine prokineticin-2 (PROK2) in Alzheimer's disease: from animal models to the human pathology 47
The multimodal antidepressant vortioxetine causes analgesia in a mouse model of chronic neuropathic pain 46
Synthesis and Biological Evaluation of 14-Alkoxymorphinans. 22. Influence of the 14-Alkoxy Group and the Substitution in Position 5 in 14-Alkoxymorphinian-6-ones on in Vitro and in Vivo Activities 45
Autoradiographic mapping of the opioid receptor-like 1 (ORL1) receptor in the brains of the mu-, delta-, kappa- opioid receptor knockout mice. 45
High-fat diet impairs duodenal barrier function and elicits glia-dependent changes along the gut-brain axis that are required for anxiogenic and depressive-like behaviors 45
A new opioid designed multiple ligand derived from the mu opioid agonist endomorphin-2 and the delta opioid antagonist pharmacophore Dmt-Tic 44
Abnormal pain sensation in mice lacking the prokineticin receptor PKR2: interaction of PKR2 with transient receptor potential TRPV1 and TRPA1 43
Serum prokineticin-2 in prepubertal and adult Klinefelter individuals 43
Production of antinociception by peripheral administration of [Lys7]dermorphin, a naturally occurring peptide with high affinity for mu-opioid receptors. 42
Antinociceptive effects and mechanism of opioid activity of [Lys7]dermorphin, a naturally occurring peptide with high affinity and selectivity for mu-opioid receptors 41
Highly Selective Fluorescent Analogue of the Potent delta-Opioid Receptor Antagonist Dmt-Tic 41
Serum substance P is increased in Parkinson's disease and correlates with motor impairment 41
Dermorphin and deltorphin glycosilated analogs: synthesis and antinociceptive activity after systemic administration 40
Identification of regions involved in the physical interaction between melanocortin receptor accessory protein 2 and prokineticin receptor 2 40
Respiratory and cardiovascular effects of the mu-opioid receptor agonist [Lys 7]dermorphin in awake rat 39
Bv8, a small protein from frog skin induces antidiuresis in rats 38
Analysis of role of aromatic residues in extracellular loop 2 of Prokineticin receptor 2 in ligand binding probed with genetically encoded photo-crosslinkers 38
A Progressive Build-up of Perineuronal Nets in the Somatosensory Cortex Is Associated with the Development of Chronic Pain in Mice 38
A new buprenorphine analog with potent antinociceptive activity never induced place preference in rats. 37
Bv8/Prokineticins and their Receptors A New Pronociceptive System. 37
HS-599: a novel long acting opioid analgesic does not induce place-prefence in rats 36
The role of prokineticin 2 in oxidative stress and in neuropathological processes 36
Prokineticin-receptor network: mechanisms of regulation 36
Knockdown of rat brain δ-opioid receptors by antisense oligodeoxynucleotides 34
PHARMACOLOGY OF BV8, A NEW PEPTIDE FROM AMPHIBIAN SKIN 33
Cardiovascular responses to the mu-opioid agonist [Lys7]dermorphin in rats 33
HALOGENATED TRIAZINEDIONES BEHAVE AS ANTAGONISTS OF PKR1: IN-VITRO ANDIN-VIVO PHARMACOLOGICAL CHARACTERIZATION 33
Differential knockdown of delta-opioid receptor subtypes in the rat brain by antisense oligodeoxynucleotides targeting mRNA. 32
Effects of antisense oligodeoxynucleotides on brain delta-opioid receptor density and on SNC80-induced locomotor stimulation and colonic transit inhibition in rats. 31
Postnatal development of delta-opioid receptor subtypes in mice 30
HALOGENATED TRIAZINEDIONES BEHAVE AS ANTAGONISTS OF PKR1: IN-VITRO AND IN-VIVO PHARMACOLOGICAL CHARACTERIZATION 30
Trypanosoma cruzi trans-sialidase induces STAT3 and ERK activation by prokineticin receptor 2 binding 29
INTERACTION BETWEEN THE MU-AGONIST DERMORPHIN AND THE DELTA-AGONIST [D-ALA(2), GLU(4)]DELTORPHIN IN SUPRASPINAL ANTINOCICEPTION AND DELTA-OPIOID RECEPTOR-BINDING 27
The novel peptide Bv8 regulates fluid intake in rats 25
Versatile role of prokineticins and prokineticin receptors in neuroinflammation 22
Increase of Prokineticin-2 in Serum of Patients with Parkinson's Disease 21
Substance P and Prokineticin-2 are overexpressed in olfactory neurons and play differential roles in persons with persistent post-COVID-19 olfactory dysfunction 20
Opioid and Bv8 Peptides 20
Non opioid motor effects of deltorphin analogs 20
Neuropeptidi 19
Differential postnatal development of delta-opioid receptor subtypes in mouse brain 19
Olfactory neuron substance P is overexpressed in Parkinson's disease reflecting gut dysfunction 19
Olfactory neuron prokineticin-2 as a potential target in Parkinson's disease 18
Glycosylated analogues of deltorphin induced antinociception after systemic administration. 18
Prokineticin 2 in cancer-related inflammation 17
Arginine 125 is an essential residue for the function of MRAP2 17
Totale 5.145
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.196
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.196
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019363 0 0 0 0 0 0 0 0 0 0 213 150
2019/20201.069 155 42 20 43 117 109 128 119 106 79 114 37
2020/2021475 46 82 36 34 4 32 2 29 78 79 41 12
2021/20221.079 15 62 96 21 130 47 36 101 116 88 159 208
2022/20231.353 211 262 119 132 150 130 11 104 98 18 79 39
2023/2024501 52 94 39 49 36 96 20 34 8 69 4 0
Totale 5.341